A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...

A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can't tolerate ...

A new gold-based drug has shown promise in slowin tumour growth in animals by 82 per cent and target cancers more selectively ...

Cadonilimab plus chemotherapy, with or without bevacizumab, could be a safe and effective treatment option, according to researchers.

In 2023, Dr Reddy's signed a licensing and commercialisation agreement with Shanghai Junshi Biosciences for Toripalimab ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...

Dr. Reddy's Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal ...

Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the ...

A study published inClinical Cancer Research found that in patients with unresectable, locally advanced esophageal cancer, ...

Dr Reddy's launches toripalimab in India for the treatment of nasopharyngeal carcinoma: Our Bureau, Bengaluru Thursday, November 28, 2024, 12:15 Hrs [IST] Dr Reddy’s Laboratorie ...